Protagonist Therapeutics
PTGX
#3331
Rank
A$5.32 B
Marketcap
$86.70
Share price
-0.19%
Change (1 day)
90.26%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2023 (TTM): -$4.02

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is -$4.24. In 2022 the company made an earnings per share (EPS) of -$4.11 an increase over its 2021 EPS that were of -$4.27.

EPS history for Protagonist Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.02-2.25%
2022-$4.11-3.7%
2021-$4.2735%
2020-$3.16-33.33%
2019-$4.7574.42%
2018-$2.72-20.74%
2017-$3.43-45.64%
2016-$6.3257.3%
2015-$4.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.45-18.66%๐Ÿ‡บ๐Ÿ‡ธ USA